Monday, October 27, 2025
- 10:30AM-12:30PM
-
Abstract Number: 1452
Clinical and Demographic Characteristics of Treatment-Refractory Axial Spondyloarthritis: Data from the Greek AxSpA Registry
(1434–1466) Spondyloarthritis Including Psoriatic Arthritis – Treatment Poster II- 10:30AM-12:30PM
-
Abstract Number: 1158
Clinical and Genetic Features of CTLA-4 Haploinsufficiency : A Prospective Study in China
(1147–1190) Miscellaneous Rheumatic & Inflammatory Diseases Poster II- 10:30AM-12:30PM
-
Abstract Number: 1167
Clinical Characteristics and Outcomes of IgG4-Related Disease Patients Who Chose Watchful Observation without Treatment Intervention: A Single-Center Study
(1147–1190) Miscellaneous Rheumatic & Inflammatory Diseases Poster II- 10:30AM-12:30PM
-
Abstract Number: 1458
Clinical Efficacy of Bimekizumab Treatment up to 2 Years Across Patients with Psoriatic Arthritis and Varying Baseline Joint Involvement: Results from a Post Hoc Analysis of Two Pooled Phase 3 Studies
(1434–1466) Spondyloarthritis Including Psoriatic Arthritis – Treatment Poster II- 10:30AM-12:30PM
-
Abstract Number: 1126
Clinical Impact of Signs of Calcium Pyrophosphate Deposition Disease (CPPD) on Radiographs of Hands and Wrists in a Real-World Cohort of Patients with Early Rheumatoid Arthritis
(1123–1146) Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster I- 10:30AM-12:30PM
-
Abstract Number: 1284
Clinical implications of Antiphospholipid Antibodies and Secondary Antiphospholipid Syndrome in Juvenile-onset Systemic Lupus Erythematosus
(1272–1305) Pediatric Rheumatology – Clinical Poster II- 10:30AM-12:30PM
-
Abstract Number: 1189
Clinical Outcomes and Response to SARS-Cov-2 Infection and Vaccination in Ianalumab‑Treated Patients with Autoimmune Diseases
(1147–1190) Miscellaneous Rheumatic & Inflammatory Diseases Poster II- 10:30AM-12:30PM
-
Abstract Number: 1305
Clinical outcomes of low-to-moderate–dose glucocorticoids in multisystem inflammatory syndrome in children (MIS-C) – a multicenter study
(1272–1305) Pediatric Rheumatology – Clinical Poster II- 10:30AM-12:30PM
-
Abstract Number: 1647
Clinical Phenotypes of Participants with Radiographic Osteoarthritis Attaining Patient Acceptable Symptom State in the Multicenter Osteoarthritis Study
(1633–1649) ARP Posters II: ARP Epidemiology & Public Health- 10:30AM-12:30PM
-
Abstract Number: 1575
Clinical presentation, course, treatment and outcome of juvenile onset versus adult onset mixed connective tissue disease patients: a multicenter retrospective cohort.
(1553–1591) Systemic Sclerosis & Related Disorders – Clinical Poster II- 10:30AM-12:30PM
-
Abstract Number: 1181
Clinical Relevance of Tumor Necrosis Factor Superfamily Cytokines
(1147–1190) Miscellaneous Rheumatic & Inflammatory Diseases Poster II- 10:30AM-12:30PM
-
Abstract Number: 1020
Cohort Study of European Ancestry, Geographic Region, Ambient Ultraviolet Irradiance and the Risk of Developing Polymyalgia Rheumatica among Women
(1007–1037) Epidemiology & Public Health Poster II- 10:30AM-12:30PM
-
Abstract Number: 1277
Combination Therapy with Rituximab and Cyclophosphamide for Treating Pediatric Patients with Severe Manifestations of Rheumatic Disease